BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38395944)

  • 21. Extensive variation in germline de novo mutations in
    Lin Y; Darolti I; van der Bijl W; Morris J; Mank JE
    Genome Res; 2023 Aug; 33(8):1317-1324. PubMed ID: 37442578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and distribution of de novo mutations in multiplex Middle Eastern families.
    Kohailan M; Aamer W; Syed N; Padmajeya S; Hussein S; Sayed A; Janardhanan J; Palaniswamy S; El Hajj N; Al-Shabeeb Akil A; Fakhro KA
    J Hum Genet; 2022 Oct; 67(10):579-588. PubMed ID: 35718832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parental mosaicism for apparent de novo genetic variants: Scope, detection, and counseling challenges.
    Zemet R; Van den Veyver IB; Stankiewicz P
    Prenat Diagn; 2022 Jun; 42(7):811-821. PubMed ID: 35394072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding de novo mutations in chromatin interactions are implicated in autism spectrum disorder.
    Kim IB; Lee T; Lee J; Kim J; Lee S; Koh IG; Kim JH; An JY; Lee H; Kim WK; Ju YS; Cho Y; Yu SJ; Kim SA; Oh M; Han DW; Kim E; Choi JK; Yoo HJ; Lee JH
    Mol Psychiatry; 2022 Nov; 27(11):4680-4694. PubMed ID: 35840799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-omics study in monozygotic twins confirm the contribution of de novo mutation to psoriasis.
    Li J; Lin H; Hou R; Shen J; Li X; Xing J; He F; Wu X; Zhao X; Sun L; Fan X; Niu X; Liu Y; Liu R; An P; Qu T; Chang W; Wang Q; Zhou L; Li J; Wang Z; Jiao J; Wang Y; Wang G; Liang N; Liang J; Liang Y; Hou H; Shi Y; Yang X; Li J; Dang E; Yin G; Yang X; Zhang G; Gao Q; Fang X; Li X; Zhang K
    J Autoimmun; 2020 Jan; 106():102349. PubMed ID: 31629629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous de novo germline mutations in humans and mice: rates, spectra, causes and consequences.
    Ohno M
    Genes Genet Syst; 2019 Apr; 94(1):13-22. PubMed ID: 30381610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications.
    Wilfert AB; Sulovari A; Turner TN; Coe BP; Eichler EE
    Genome Med; 2017 Nov; 9(1):101. PubMed ID: 29179772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased exonic de novo mutation rate in individuals with schizophrenia.
    Girard SL; Gauthier J; Noreau A; Xiong L; Zhou S; Jouan L; Dionne-Laporte A; Spiegelman D; Henrion E; Diallo O; Thibodeau P; Bachand I; Bao JY; Tong AH; Lin CH; Millet B; Jaafari N; Joober R; Dion PA; Lok S; Krebs MO; Rouleau GA
    Nat Genet; 2011 Jul; 43(9):860-3. PubMed ID: 21743468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large, three-generation human families reveal post-zygotic mosaicism and variability in germline mutation accumulation.
    Sasani TA; Pedersen BS; Gao Z; Baird L; Przeworski M; Jorde LB; Quinlan AR
    Elife; 2019 Sep; 8():. PubMed ID: 31549960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parent-of-origin-specific signatures of de novo mutations.
    Goldmann JM; Wong WS; Pinelli M; Farrah T; Bodian D; Stittrich AB; Glusman G; Vissers LE; Hoischen A; Roach JC; Vockley JG; Veltman JA; Solomon BD; Gilissen C; Niederhuber JE
    Nat Genet; 2016 Aug; 48(8):935-9. PubMed ID: 27322544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncoding de novo mutations in
    Zhang Y; Ahsan MU; Wang K
    medRxiv; 2024 May; ():. PubMed ID: 38766206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.
    Liu Y; Liang Y; Cicek AE; Li Z; Li J; Muhle RA; Krenzer M; Mei Y; Wang Y; Knoblauch N; Morrison J; Zhao S; Jiang Y; Geller E; Ionita-Laza I; Wu J; Xia K; Noonan JP; Sun ZS; He X
    Am J Hum Genet; 2018 Jun; 102(6):1031-1047. PubMed ID: 29754769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases.
    Mao F; Liu Q; Zhao X; Yang H; Guo S; Xiao L; Li X; Teng H; Sun Z; Dou Y
    Nucleic Acids Res; 2018 Jan; 46(D1):D92-D99. PubMed ID: 29040751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.
    Hamdan FF; Gauthier J; Araki Y; Lin DT; Yoshizawa Y; Higashi K; Park AR; Spiegelman D; Dobrzeniecka S; Piton A; Tomitori H; Daoud H; Massicotte C; Henrion E; Diallo O; ; Shekarabi M; Marineau C; Shevell M; Maranda B; Mitchell G; Nadeau A; D'Anjou G; Vanasse M; Srour M; Lafrenière RG; Drapeau P; Lacaille JC; Kim E; Lee JR; Igarashi K; Huganir RL; Rouleau GA; Michaud JL
    Am J Hum Genet; 2011 Mar; 88(3):306-16. PubMed ID: 21376300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Study of De Novo Mutations on the Protein-Protein Interaction Interfaces Provides New Insights into Developmental Delay.
    Maharjan DT; Song W; Liu Z; Wang W; Cai W; Chen J; Xu F; Ying W; Lin GN
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes.
    Hathy E; Szabó E; Varga N; Erdei Z; Tordai C; Czehlár B; Baradits M; Jezsó B; Koller J; Nagy L; Molnár MJ; Homolya L; Nemoda Z; Apáti Á; Réthelyi JM
    Stem Cell Res Ther; 2020 Nov; 11(1):504. PubMed ID: 33246498
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Alonso-Gonzalez A; Rodriguez-Fontenla C; Carracedo A
    Front Genet; 2018; 9():406. PubMed ID: 30298087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive de novo mutation discovery with HiFi long-read sequencing.
    Kucuk E; van der Sanden BPGH; O'Gorman L; Kwint M; Derks R; Wenger AM; Lambert C; Chakraborty S; Baybayan P; Rowell WJ; Brunner HG; Vissers LELM; Hoischen A; Gilissen C
    Genome Med; 2023 May; 15(1):34. PubMed ID: 37158973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population.
    Kessler MD; Loesch DP; Perry JA; Heard-Costa NL; Taliun D; Cade BE; Wang H; Daya M; Ziniti J; Datta S; Celedón JC; Soto-Quiros ME; Avila L; Weiss ST; Barnes K; Redline SS; Vasan RS; Johnson AD; Mathias RA; Hernandez R; Wilson JG; Nickerson DA; Abecasis G; Browning SR; Zöllner S; O'Connell JR; Mitchell BD; ; ; O'Connor TD
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2560-2569. PubMed ID: 31964835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo mutation hotspots in homologous protein domains identify function-altering mutations in neurodevelopmental disorders.
    Wiel L; Hampstead JE; Venselaar H; Vissers LELM; Brunner HG; Pfundt R; Vriend G; Veltman JA; Gilissen C
    Am J Hum Genet; 2023 Jan; 110(1):92-104. PubMed ID: 36563679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.